FSP1 can utilize NAD(P)H and oxidized CoQ10 as substrates to generate NAD(P)+ and reduced CoQ10, thus inhibiting ferroptosis in GPX4-depleted NSCLC cells (Bersuker et al. 2019). The gene discussed is GPX4; the disease is non-small cell lung carcinoma.